Cargando…
Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics
Cancer is generally considered a result of genetic mutations that cause epigenetic changes, leading to anomalous cellular behavior. Since 1970s, an increasing understanding of the plasma membrane and specifically the lipid alterations in tumor cells have provided novel insights for cancer therapy. M...
Autores principales: | Fei, Weidong, Yan, Jingjing, Wu, Xiaodong, Yang, Shan, Zhang, Xiao, Wang, Rong, Chen, Yue, Xu, Junjun, Zheng, Caihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196822/ https://www.ncbi.nlm.nih.gov/pubmed/37215569 http://dx.doi.org/10.7150/thno.82189 |
Ejemplares similares
-
Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic Paradigm
por: Sohrab, Sayed Sartaj, et al.
Publicado: (2023) -
Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine
por: Li, Min, et al.
Publicado: (2022) -
Lipid-engineered nanotherapeutics for cancer management
por: Fernandez-Fernandez, Alicia, et al.
Publicado: (2023) -
Nanotherapeutics: Engineering Cell Membrane‐Based Nanotherapeutics to Target Inflammation (Adv. Sci. 15/2019)
por: Yan, Huize, et al.
Publicado: (2019) -
Editorial: Oral Nanotherapeutics for Colon Diseases
por: Duan, Lian, et al.
Publicado: (2021)